Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06122961 · ClinicalTrials.gov registry record
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
A clinical trial of Heart Failure and Chronic Kidney Disease, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 18,198
- Enrollment target
- 20
- Study locations
NCT06122961: Completed study of Heart Failure and Chronic Kidney Disease, sponsored by Novo Nordisk A/S.
NCT06122961 is a study of Heart Failure and Chronic Kidney Disease that has completed, run by Novo Nordisk A/S. The registered enrollment target is 18,198 participants, above the 2,003-participant average among 397 other Heart Failure trials with a reported enrollment target (809% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06122961, a study of Heart Failure and Chronic Kidney Disease, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 18,198 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease). Participants will continue their normal care and will not get any treatment other than those the study doctor has prescribed.
Primary Outcome
Count of patient
Conditions Studied
Interventions
- OTHER No treatment given
Study Locations (20)
Buenos Aires
- Hospital Italiano Regional Sur - Bahía Blanca
- Clínica Coronel Suarez - Coronel Suárez
- Hospital Italiano de la Plata - La Plata
- Centro Médico CIMEL - Lanús Este
Other
- DIM Clinica Privada - Buenos Aires
- Instituto de Investigaciones Clinicas Quilmes SRL - Buenos Aires
- Instituto Médico DAMIC - Córdoba
- Hospital Luis Lagomaggiore - Mendoza
São Paulo
- i9 Pesquisas Clínicas - Campinas
- Hospital Alemão Oswaldo Cruz - São Paulo
California
- Mission Cardiovascular Research Institute - Fremont
Texas
- Texas Institute of Cardiology PA - McKinney
Buenos Aires, Argentina
- Fundacion Favaloro - CABA
Santa Fe Province
- INECO Neurociencias Oroño - Rosario
New South Wales
- Renal Research Gosford - Gosford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,198 participants |
| Start Date | 2023-11-23 |
| Est. Completion | 2025-04-30 |
What the finished NCT06122961 record still lists
NCT06122961 is an observational study that tracks outcomes without assigning an intervention. Its 18,198 participants enrollment target places it among the larger protocols in the corpus, above the 2,003-participant average among 397 other Heart Failure trials with a reported enrollment target (809% higher).
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which No treatment given is the first listed.
NCT06122961 names 20 study sites across 13 states, led by Buenos Aires, Other, São Paulo.
Frequently Asked Questions
What is clinical trial NCT06122961 about?
NCT06122961 is a clinical study titled "Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)". This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease). Participants will continue their normal care and will not get any treatment other than those the study doctor has prescribed.
What is the current status of trial NCT06122961?
This trial is currently completed. The enrollment target is 18,198 participants. The study started on 2023-11-23. Estimated completion is 2025-04-30.
What conditions does trial NCT06122961 study?
This clinical trial studies the following conditions: Heart Failure, Chronic Kidney Disease, Cardiovascular Risk.
What interventions are being tested in trial NCT06122961?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT06122961?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06122961 being conducted?
This trial has 20 study locations across California, Texas, Buenos Aires, Buenos Aires, Argentina, Santa Fe Province. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06122961's enrollment target sits among peer trials
18,198 10th of 397 higher than 388 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04110522 · 18,000 participants · NA
Psoriatic Arthritis D2P Screening
- NCT05513833 · 18,000 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
- NCT06802224 · 18,000 participants · Phase 4
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
- NCT04372875 · 18,500 participants · NA
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI